Suven Life Sciences Limited logo

SUVEN

NSE
Suven Life Sciences Limited (SMALL CAP)
Healthcare>Healthcare>Healthcare Services>Healthcare Research Analytics & Technology
357.85
11.10 (3.20%)
High VOLATILITY
As on 10 Jul 2026

Price History

Market Cap
₹8.14K Cr
SMALL CAP
P/E Ratio
N/A
Industry
Healthcare Research Analytics & Technology
52-Week Range
52W Low124.11+188.3%
52W High370.8-3.5%
Current Price
357.85
Circuit Limits (20%)
Lower Circuit286.28
Upper Circuit429.42
Reference Price
357.85

Investment Checklist

Composite score 68.93 (STRONG_BUY) with 57.5% confidence
3-day momentum: +12.1% — strong upward pressure
Trend: Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)
RSI at 75.6 — overbought, pullback risk
SuperTrend(10,3): Price above SuperTrend (Industry Standard (Swing/Medium-Term))

Technical Analysis

Technical Analysis

Analysis from 2026-07-11

Confidence
58%

Trend

BULLISH
BULLISH

Price above all key MAs — strong uptrend | Bullish MA stack (20>50>200)

EMA20
297.07
EMA50
264.25
EMA200
221.17

Price Action

UPTREND
BULLISH
Higher Highs6
Higher Lows7
Lower Highs3
Lower Lows2

Support & Resistance Levels

Resistance (Above)
No recent resistance detected
Support (Below)
298.97
252.65
235.67
230.14
227.00

Volume Analysis

TrendINCREASING
Change+89.10%
Unusual VolumeNo

Stop Loss Levels

Fixed Risk

1% Risk354.27
3% Risk347.11
5% Risk339.96
7% Risk (Custom)
332.80

Technical Levels

1x ATR (Volatility)337.00
2x ATR (Swing)316.15
3x ATR (Trend)295.30
Immediate Support298.97

Moving Averages

EMA 9 (Short-term)319.75
EMA 20 (Medium-term)297.07
EMA 50 (Trend)264.25
EMA 200 (Long-term)221.17

Financials

Financial Analysis

MetricMar '25Jun '25Sep '25Dec '25
Revenue₹1.5 Cr₹1.9 Cr₹91,92,000₹2.8 Cr
Net Profit₹-43.9 Cr₹-51.5 Cr₹-77.3 Cr₹-101.9 Cr
EPS₹-2.36₹-3.48₹-4.55
Operating Profit₹-42.6 Cr₹-50.1 Cr₹-76 Cr₹-100.6 Cr
ROE
-146.15%
ROCE
-146.11%
Debt/Equity
0.00
Current Ratio
3.21
OPM
-3580.87%
NPM
-3628.79%

Peer Comparison

Healthcare Research Analytics & Technology

Peer Comparison

Symbol
Name
Price
Change
P/E Ratio
Market Cap
Syngene International Limited₹420.35+1.19%53.6
₹16.94K Cr
Indegene Limited₹509.30+2.69%30.6
₹12.25K Cr
Suven Life Sciences Limited₹357.85+3.20%
₹8.14K Cr
Vimta Labs Limited₹566.10+1.29%32.6
₹2.53K Cr
Take Solutions Limited₹22.66-4.02%85.3
₹335 Cr
Bilcare Limited₹63.06-2.40%
₹148 Cr

Corporate Information

Large Deals

View All

Bulk, Block and Short deals reported for this stock.

Loading Deals...

Corporate Actions

Recent actions

View All
Ex DatePurposeType
30 Jul 2024
Annual General Meeting
AGM
02 Aug 2023
Annual General Meeting
AGM
17 Oct 2022
Rights 1:2 @ Premium Rs 54/-
RIGHTS_ISSUE
29 Jul 2022
Annual General Meeting
AGM
02 Aug 2021
Annual General Meeting
AGM

Announcements

Latest updates

View All
DateDescriptionLink
10 Jul 2026
Press Release
08 Jul 2026
Certificate under SEBI (Depositories and Participants) Regulations, 2018
08 Jul 2026
General Updates
08 Jul 2026
General Updates
08 Jul 2026
Change in Management

Board Meetings

Upcoming and past meetings

View All
DatePurposeLinks
13 May 2026
Board Meeting Intimation
29 Jan 2026
Financial Results
29 Jan 2026
Board Meeting Intimation
11 Nov 2025
Board Meeting Intimation
11 Nov 2025
Financial Results

Corporate Events

Upcoming results & meetings

View All

No upcoming events found

We couldn't find any scheduled corporate actions for this symbol at the moment.

Shareholding Pattern

Shareholding Pattern

As of Dec 2025

Current Distribution

Trend (Last 8 Qtrs)

Latest News

News for SUVEN

View All
Pharma stocks: Lupin, Torrent hit new peaks; Sun nears summit; here's why
positive
Business Standard - Markets 3d ago

Pharma stocks: Lupin, Torrent hit new peaks; Sun nears summit; here's why

Pharma stock rally: Orchid Pharma, Hikal, Unichem Labs, IOL Chemicals, SPARC, RPG Life Sciences and Acutaas Chemicals surged up to 13% in Wednesday's trade.

ABGSECABSL10BANKABSLAMCABSLBANETFABSLLIQUIDABSLNN50ETABSLPSEACUTAASALIVUSBSLGOLDETFBSLNIFTYBSLSENETFGGSEC10ABSLHEALTHYHIKALIOLCPJFLLIFEJFL-REJGCHEMLUPINMOMENTUMNIFTYQLITYORCHPHARMARPGLIFESAILIFESILVERSOLARASPARCSUVENTECHChemicalsFinancial Services
Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection
negative
LiveMint - Companies 4d ago

Reliance's Strand Life Sciences secures Indian patent for blood-based early cancer detection

The patented platform combines genome sequencing, methylation analysis and machine learning to detect cancer and identify its tissue of origin from a single blood sample.

ABGSECALIVUSJFLLIFEJFL-RERELIANCERELINFRARPGLIFESAILIFESUVENFinancial ServicesHealthcare
Market Trading Guide: Suven Life Sciences among 2 stock recommendations for Friday - The Economic Times
neutral
Google News - India Markets 9d ago

Market Trading Guide: Suven Life Sciences among 2 stock recommendations for Friday - The Economic Times

Market Trading Guide: Suven Life Sciences among 2 stock recommendations for FridayThe Economic Times

ALIVUSJFLLIFEJFL-RERPGLIFESAILIFESUVENHealthcare

Frequently Asked Questions